Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $12.5B |
| FY2017, ended Dec 31, 2017 | $22.8B |
| FY2018, ended Dec 31, 2018 | $32.1B |
| FY2019, ended Dec 31, 2019 | $53.6B |
| FY2020, ended Dec 31, 2020 | $108B |
| FY2021, ended Dec 31, 2021 | $130B |
| FY2022, ended Dec 31, 2022 | $78.8B |
| FY2023, ended Dec 31, 2023 | $145B |
| FY2024, ended Dec 31, 2024 | $218B |
| FY2025, ended Dec 31, 2025 | $160B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $103B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.39B |
| FY2017, ended Dec 31, 2017 | $1.93B |
| FY2018, ended Dec 31, 2018 | $2.61B |
| FY2019, ended Dec 31, 2019 | $3.46B |
| FY2020, ended Dec 31, 2020 | $4.52B |
| FY2021, ended Dec 31, 2021 | $5.90B |
| FY2022, ended Dec 31, 2022 | $7.25B |
| FY2023, ended Dec 31, 2023 | $8.97B |
| FY2024, ended Dec 31, 2024 | $11.0B |
| FY2025, ended Dec 31, 2025 | $13.3B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $14.7B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | −$414M | $53.5M |
| FY2017, ended Dec 31, 2017 | −$117M | $492M |
| FY2018, ended Dec 31, 2018 | −$26.7M | $587M |
| FY2019, ended Dec 31, 2019 | $627M | $971M |
| FY2020, ended Dec 31, 2020 | $119M | $1.37B |
| FY2021, ended Dec 31, 2021 | $230M | $1.80B |
| FY2022, ended Dec 31, 2022 | $325M | $2.17B |
| FY2023, ended Dec 31, 2023 | $1.73B | $2.70B |
| FY2024, ended Dec 31, 2024 | $1.43B | $3.42B |
| FY2025, ended Dec 31, 2025 | $1.75B | $4.58B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.67B | $4.58B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $401M |
| FY2017, ended Dec 31, 2017 | $726M |
| FY2018, ended Dec 31, 2018 | $566M |
| FY2019, ended Dec 31, 2019 | $776M |
| FY2020, ended Dec 31, 2020 | $1.68B |
| FY2021, ended Dec 31, 2021 | $1.73B |
| FY2022, ended Dec 31, 2022 | $1.47B |
| FY2023, ended Dec 31, 2023 | $1.90B |
| FY2024, ended Dec 31, 2024 | $2.30B |
| FY2025, ended Dec 31, 2025 | $3.73B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.50B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $508M |
| FY2017, ended Dec 31, 2017 | $1.17B |
| FY2018, ended Dec 31, 2018 | $662M |
| FY2019, ended Dec 31, 2019 | $748M |
| FY2020, ended Dec 31, 2020 | $1.64B |
| FY2021, ended Dec 31, 2021 | $1.58B |
| FY2022, ended Dec 31, 2022 | $1.49B |
| FY2023, ended Dec 31, 2023 | $1.49B |
| FY2024, ended Dec 31, 2024 | $1.49B |
| FY2025, ended Dec 31, 2025 | $1.49B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $7.52B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 23.1% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 840M |
| FY2017, ended Dec 31, 2017 | 874M |
| FY2018, ended Dec 31, 2018 | 903M |
| FY2019, ended Dec 31, 2019 | 949M |
| FY2020, ended Dec 31, 2020 | 981M |
| FY2021, ended Dec 31, 2021 | 1.00B |
| FY2022, ended Dec 31, 2022 | 1.01B |
| FY2023, ended Dec 31, 2023 | 1.02B |
| FY2024, ended Dec 31, 2024 | 1.03B |
| FY2025, ended Dec 31, 2025 | 1.05B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 1.03B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $0 | $318M | — |
| FY2017, ended Dec 31, 2017 | $55.0M | $394M | — |
| FY2018, ended Dec 31, 2018 | $0 | $544M | — |
| FY2019, ended Dec 31, 2019 | $0 | $662M | — |
| FY2020, ended Dec 31, 2020 | — | $870M | — |
| FY2021, ended Dec 31, 2021 | $0 | $1.13B | $6.00M |
| FY2022, ended Dec 31, 2022 | $0 | $1.40B | — |
| FY2023, ended Dec 31, 2023 | $538M | $1.60B | — |
| FY2024, ended Dec 31, 2024 | $696M | $1.75B | — |
| FY2025, ended Dec 31, 2025 | $1.84B | $1.96B | $1.90B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $3.41B | $2.19B | — |
Valuation
At current price- Market Cap
- $160B
- P/E
- 95.8×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 10.9×
- Price / Book
- 12.8×
- EV / EBITDA
- 60.0×
Growth
Trailing 12 months- Revenue (TTM)
- $14.7B
- Revenue Growth YoY
- 22.2%
- Revenue CAGR 3Y
- 22.4%
- Revenue CAGR 5Y
- 24.1%
- EPS Growth YoY
- n/m. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- 0.5%
Profitability
Trailing 12 months- Gross Margin
- 74.8%
- Operating Margin
- 11.4%
- Net Margin
- 11.3%
- FCF Margin
- 31.1%
- Return on Equity
- 14.2%
Earnings
Trailing 12 months- Net Income
- $1.67B
- EPS (diluted)
- $1.60
- EBITDA
- $2.75B
- Operating Income
- $1.68B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $2.50B
- Total Debt
- $7.52B
- Net Debt
- $5.01B
- Total Assets
- $31.7B
- Total Liabilities
- $19.1B
- Shareholders' Equity
- $12.5B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $5.31B
- Capital Expenditure
- $728M
- Free Cash Flow
- $4.58B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 0.99
Every ratio is calculated from the company’s reported figures.